SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-16-582769
Filing Date
2016-05-09
Accepted
2016-05-09 07:36:35
Documents
4
Period of Report
2016-05-09
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d177435d8k.htm 8-K 14779
2 EX-99.1 d177435dex991.htm EX-99.1 64440
3 GRAPHIC g177435g04s82.jpg GRAPHIC 1901
4 GRAPHIC g177435g98t84.jpg GRAPHIC 3919
  Complete submission text file 0001193125-16-582769.txt   88665
Mailing Address 85 WELLS AVENUE SECOND FLOOR NEWTON MA 02459
Business Address 85 WELLS AVENUE SECOND FLOOR NEWTON MA 02459 617-658-0600
Karyopharm Therapeutics Inc. (Filer) CIK: 0001503802 (see all company filings)

IRS No.: 263931704 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36167 | Film No.: 161629920
SIC: 2834 Pharmaceutical Preparations